Novel Potential Markers of Myofibroblast Differentiation Revealed by Single-Cell RNA Sequencing Analysis of Mesenchymal Stromal Cells in Profibrotic and Adipogenic Conditions.

fibrosis gene expression multipotent mesenchymal stromal cells myofibroblast single-cell transcriptome

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
10 Mar 2023
Historique:
received: 15 02 2023
revised: 03 03 2023
accepted: 07 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Mesenchymal stromal cells (MSCs) are the key regulators of tissue homeostasis and repair after damage. Accumulating evidence indicates the dual contribution of MSCs into the development of fibrosis induced by chronic injury: these cells can suppress the fibrotic process due to paracrine activity, but their promoting role in fibrosis by differentiating into myofibroblasts has also been demonstrated. Many model systems reproducing fibrosis have shown the ability of peroxisome proliferator-activated receptor (PPAR) agonists to reverse myofibroblast differentiation. Thus, the differentiation of multipotent cells into myofibroblasts and adipocytes can be considered as processes that require the activation of opposite patterns of gene expression. To test this hypothesis, we analyzed single cell RNA-Seq transcriptome of human adipose tissue MSCs after stimulation of the myofibroblast or adipogenic differentiation and revealed several genes that changed their expression in a reciprocal manner upon these conditions. We validated the expression of selected genes by RT-PCR, and evaluated the upregulation of several relevant proteins using immunocytochemistry, refining the results obtained by RNA-Seq analysis. We have shown, for the first time, the expression of neurotrimin (NTM), previously studied mainly in the nervous tissue, in human adipose tissue MSCs, and demonstrated its increased gene expression and clustering of membrane receptors upon the stimulation of myofibroblast differentiation. We also showed an increased level of CHD3 (Chromodomain-Helicase-DNA-binding protein 3) in MSCs under profibrotic conditions, while retinol dehydrogenase-10 (RDH10) was detected only in MSCs after adipogenic induction, which contradicted the data of transcriptomic analysis and again highlights the need to validate the data obtained by omics methods. Our findings suggest the further analysis of the potential contribution of neurotrimin and CHD3 in the regulation of myofibroblast differentiation and the development of fibrosis.

Identifiants

pubmed: 36979822
pii: biomedicines11030840
doi: 10.3390/biomedicines11030840
pmc: PMC10045579
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Russian Foundation for Basic Research
ID : 21-315-70002

Références

Clin Biochem. 2016 Aug;49(12):903-8
pubmed: 27234597
JCI Insight. 2019 Nov 1;4(21):
pubmed: 31581150
Mol Biol Cell. 2003 Jun;14(6):2508-19
pubmed: 12808047
Nat Commun. 2016 Jul 22;7:12260
pubmed: 27447449
J Neurosci. 1998 Nov 15;18(22):9312-25
pubmed: 9801370
Front Cell Dev Biol. 2020 Sep 22;8:555378
pubmed: 33072743
Nat Struct Mol Biol. 2011 Jun 05;18(7):831-9
pubmed: 21642969
Exp Cell Res. 2019 Jun 1;379(1):119-128
pubmed: 30910400
Cells. 2020 May 20;9(5):
pubmed: 32443855
Bull Exp Biol Med. 2021 Aug;171(4):523-531
pubmed: 34542758
Front Oncol. 2020 Nov 27;10:581007
pubmed: 33330058
Stem Cell Res Ther. 2020 Apr 6;11(1):149
pubmed: 32252818
Sci Transl Med. 2014 Apr 16;6(232):232ra50
pubmed: 24739758
Sci Rep. 2018 Dec 21;8(1):18021
pubmed: 30575813
Int J Biochem Cell Biol. 1997 Oct;29(10):1145-8
pubmed: 9438378
J Bone Miner Res. 2021 Dec;36(12):2399-2412
pubmed: 34423861
Stem Cell Res Ther. 2015 Nov 11;6:221
pubmed: 26560317
Mol Syst Biol. 2022 May;18(5):e10947
pubmed: 35579278
Wound Repair Regen. 2021 Jul;29(4):678-691
pubmed: 34117675
Matrix Biol. 2015 Mar;42:74-92
pubmed: 25549589
Int J Mol Med. 2019 Apr;43(4):1643-1656
pubmed: 30720061
Exp Hematol. 1976 Sep;4(5):267-74
pubmed: 976387
Tissue Eng. 2001 Apr;7(2):211-28
pubmed: 11304456
Cell Stem Cell. 2021 Oct 7;28(10):1690-1707
pubmed: 34624231
Exp Eye Res. 2021 Jun;207:108594
pubmed: 33894227
Curr Opin Neurobiol. 2019 Dec;59:59-68
pubmed: 31146125
FASEB J. 2021 Dec;35(12):e22016
pubmed: 34784434
Nat Commun. 2020 Feb 28;11(1):1064
pubmed: 32111836
Oncotarget. 2017 Sep 23;8(52):90579-90604
pubmed: 29163854
Sci Transl Med. 2018 Jan 31;10(426):
pubmed: 29386358
Cells. 2019 May 16;8(5):
pubmed: 31100966
Curr Opin Pharmacol. 2010 Dec;10(6):684-91
pubmed: 20817607
Cell. 2021 Jun 24;184(13):3573-3587.e29
pubmed: 34062119
Int J Mol Sci. 2019 Apr 03;20(7):
pubmed: 30987106
EMBO J. 2001 Mar 1;20(5):1114-22
pubmed: 11230134
Matrix Biol. 2015 Jan;41:26-35
pubmed: 25433338
J Cell Sci. 2016 Aug 15;129(16):3115-29
pubmed: 27378169
Biomolecules. 2020 Mar 23;10(3):
pubmed: 32210029
Nat Rev Rheumatol. 2020 Jan;16(1):11-31
pubmed: 31792399
Exp Neurol. 2006 Mar;198(1):54-64
pubmed: 16336965
Cytotherapy. 2006;8(4):315-7
pubmed: 16923606
Cardiovasc Res. 2015 Apr 1;106(1):32-42
pubmed: 25694587
Am J Pathol. 1991 May;138(5):1257-65
pubmed: 2024710
Kidney Int. 1992 Mar;41(3):530-2
pubmed: 1573823
Int J Biol Sci. 2021 Oct 11;17(15):4192-4206
pubmed: 34803492
Mol Nutr Food Res. 2021 Oct;65(19):e2100367
pubmed: 34331380
J Invest Dermatol. 2007 Mar;127(3):526-37
pubmed: 17299435
Matrix Biol. 2018 Aug;68-69:81-93
pubmed: 29408013
Dev Cell. 2016 May 23;37(4):311-325
pubmed: 27184734
Acta Ophthalmol. 2011 Mar;89(2):e115-21
pubmed: 20528783

Auteurs

Olga Grigorieva (O)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Lomonosovsky Ave., 27/10, 119192 Moscow, Russia.

Nataliya Basalova (N)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Lomonosovsky Ave., 27/10, 119192 Moscow, Russia.

Maksim Vigovskiy (M)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Lomonosovsky Ave., 27/10, 119192 Moscow, Russia.
Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Mikhail Arbatskiy (M)

Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Uliana Dyachkova (U)

Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Maria Kulebyakina (M)

Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Konstantin Kulebyakin (K)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Lomonosovsky Ave., 27/10, 119192 Moscow, Russia.
Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Pyotr Tyurin-Kuzmin (P)

Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Natalia Kalinina (N)

Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Anastasia Efimenko (A)

Institute for Regenerative Medicine, Medical Research and Education Center, Lomonosov Moscow State University, Lomonosovsky Ave., 27/10, 119192 Moscow, Russia.
Faculty of Medicine, Lomonosov Moscow State University, Lomonosovsky Ave., 27/1, 119991 Moscow, Russia.

Classifications MeSH